Answer
Vanflyta treats newly diagnosed FLT3-ITD-positive acute myeloid leukaemia in adults, in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by Vanflyta alone as maintenance therapy.
Sources for this answer
- Vanflyta 17.7 mg film-coated tabletDaiichi Sankyo UK Limited · emc · SmPC §4.1 Therapeutic Indications · Version 4Document updated
Sources checked